Sumanta K Pal Selected Research

Sumanta K Pal Research Topics

Disease

148	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 08/2011
100	Neoplasms (Cancer) 04/2024 - 09/2011
37	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 09/2011
28	Carcinoma (Carcinomatosis) 10/2023 - 04/2015
26	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2012
22	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2012
18	Kidney Neoplasms (Kidney Cancer) 04/2024 - 05/2012
11	Disease Progression 01/2022 - 04/2016
6	Urogenital Neoplasms 10/2023 - 01/2017
5	Breast Neoplasms (Breast Cancer) 12/2012 - 01/2010
4	Circulating Neoplastic Cells 01/2021 - 05/2015
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2015
4	Fatigue 01/2020 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2024 - 08/2023
2	Infections 12/2023 - 08/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2020
2	Hyperphosphatemia 12/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2020 - 05/2012
2	Liver Neoplasms (Liver Cancer) 12/2019 - 05/2015
2	Hand-Foot Syndrome 10/2019 - 04/2018
2	Mucositis 10/2019 - 04/2018
2	Anemia 07/2017 - 04/2015
2	Diarrhea 12/2015 - 05/2012

Drug/Important Bio-Agent (IBA)

29	Immune Checkpoint InhibitorsIBA 04/2024 - 12/2017
22	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2013
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2014
18	Sunitinib (Sutent)FDA Link 12/2022 - 02/2014
17	NivolumabIBA 01/2024 - 10/2017
15	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2014
14	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2012
13	IpilimumabIBA 12/2023 - 01/2015
11	cabozantinibIBA 01/2023 - 01/2019
10	Everolimus FDA Link 01/2023 - 11/2014
10	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2015
9	tivozanibIBA 01/2024 - 12/2012
9	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2024 - 07/2013
9	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 05/2012
8	Circulating Tumor DNAIBA 01/2023 - 05/2017
8	PlatinumIBA 12/2021 - 01/2017
7	Gemcitabine FDA Link 01/2024 - 05/2013
7	Axitinib (AG 013736)IBA 01/2023 - 05/2012
7	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2012
7	AndrogensIBA 04/2019 - 09/2011
6	infigratinibIBA 04/2024 - 01/2018
6	pazopanib FDA Link 03/2024 - 01/2017
6	atezolizumabIBA 11/2021 - 10/2017
6	Docetaxel (Taxotere)FDA Link 09/2021 - 11/2012
6	TOR Serine-Threonine KinasesIBA 06/2016 - 10/2014
5	ParaffinIBA 01/2023 - 05/2015
5	Formaldehyde (Formol)FDA Link 01/2023 - 05/2015
5	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2018
5	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2013
5	enzalutamideIBA 01/2021 - 04/2013
5	LigandsIBA 01/2021 - 01/2018
4	pembrolizumabIBA 10/2023 - 10/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
4	MTOR InhibitorsIBA 06/2016 - 11/2013
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
3	PPAR gammaIBA 01/2020 - 05/2018
3	CytokinesIBA 04/2019 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	Toll-Like Receptor 9IBA 12/2018 - 12/2013
3	taxaneIBA 06/2015 - 01/2010
2	VaccinesIBA 01/2023 - 07/2013
2	AntibodiesIBA 01/2023 - 04/2015
2	Peptides (Polypeptides)IBA 01/2022 - 07/2013
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 12/2014
2	Monoclonal AntibodiesIBA 01/2022 - 01/2015
2	CateninsIBA 02/2021 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2013
2	abirateroneIBA 01/2021 - 04/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 10/2020
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2020 - 01/2018
2	avelumabIBA 11/2020 - 10/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 04/2015
2	Warfarin (Coumadin)FDA LinkGeneric 02/2017 - 01/2017
2	temsirolimus FDA Link 04/2016 - 11/2014
2	cabazitaxel FDA Link 12/2015 - 12/2012
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2015 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015 - 12/2012
2	Methotrexate (Mexate)FDA LinkGeneric 08/2015 - 12/2012
2	Vinblastine (Vinblastine Sulfate)FDA Link 08/2015 - 12/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015 - 01/2014

Therapy/Procedure

133	Therapeutics 03/2024 - 04/2010
38	Immunotherapy 04/2024 - 09/2011
21	Castration 02/2024 - 09/2011
20	Drug Therapy (Chemotherapy) 01/2023 - 04/2010
13	Nephrectomy 10/2023 - 06/2014
11	Cystectomy 11/2023 - 05/2013
6	Radiotherapy 01/2023 - 12/2013
5	Neoadjuvant Therapy 10/2020 - 05/2013
4	Adjuvant Chemotherapy 07/2022 - 03/2016
3	Metastasectomy 03/2024 - 01/2017
3	Precision Medicine 01/2021 - 01/2020
2	Organ Sparing Treatments 01/2024 - 11/2023
2	Drug Tapering 10/2021 - 04/2018
2	Prostatectomy (Retropubic Prostatectomy) 12/2018 - 01/2017
2	Chemoradiotherapy 04/2018 - 10/2016
2	Ligation 03/2016 - 01/2016